{
    "organizations": [],
    "uuid": "4baea32a97b694733221dcbc047ded7097509632",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neos-therapeutics-reiterates-confi/brief-neos-therapeutics-reiterates-confidence-in-strategic-plan-and-value-creation-opportunities-idUSFWN1QA0TK",
    "ord_in_thread": 0,
    "title": "BRIEF-Neos Therapeutics Reiterates Confidence In Strategic Plan And Value Creation Opportunities | Reuters",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Neos Therapeutics Inc:\n* NEOS THERAPEUTICS REITERATES CONFIDENCE IN STRATEGIC PLAN AND VALUE CREATION OPPORTUNITIES\n* NEOS THERAPEUTICS - “CONFIDENT IN CO‘S STRATEGIC PLAN”, IN LIGHT OF PDL BIOPHARMA TERMINATING INTEREST IN CO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-20T23:43:00.000+02:00",
    "crawled": "2018-02-20T17:51:19.037+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "neos",
        "therapeutic",
        "inc",
        "neos",
        "therapeutic",
        "reiterates",
        "confidence",
        "strategic",
        "plan",
        "value",
        "creation",
        "opportunity",
        "neos",
        "therapeutic",
        "confident",
        "co",
        "strategic",
        "plan",
        "light",
        "pdl",
        "biopharma",
        "terminating",
        "interest",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}